Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201009284341N2Phase 2Completed
Phase 2, open-label, single-arm trial of papaverine in sexual dysfunction, sponsored by Iran University of Medical Sciences. Primary endpoint: Cavernosal artery blood flow velocity. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201009284341N2.